Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials using LSD to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Karlin first fills Abby and Patrick in about those disorders, MindMed’s ongoing clinical trials, and both the history of LSD research and potential near-future therapeutic applications. In the wide-ranging c...
All content for Ordinary Unhappiness is the property of Patrick & Abby and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials using LSD to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Karlin first fills Abby and Patrick in about those disorders, MindMed’s ongoing clinical trials, and both the history of LSD research and potential near-future therapeutic applications. In the wide-ranging c...
Abby and Patrick welcome writer and academic Michael Clune to discuss his new novel, Pan. It is the story of Nick, a teenage boy living alone with his divorced father in the 1990s Midwest. Precocious but troubled, he begins to suffer from panic attacks, obsessional symptoms, and more. Nick’s voice narrates these and other experiences with rich texture, yet his internal monologue steadily pushes the reader to question where and how the tumultuous life of a normal teenager ends and pathology be...
Ordinary Unhappiness
Abby and Patrick continue their series on psychedelics via an in-depth interview with Dr. Dan Karlin. Karlin is a psychiatrist and Chief Medical Officer at MindMed, where he oversees clinical trials using LSD to treat major depressive disorder (MDD) and generalized anxiety disorder (GAD). Karlin first fills Abby and Patrick in about those disorders, MindMed’s ongoing clinical trials, and both the history of LSD research and potential near-future therapeutic applications. In the wide-ranging c...
